{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:10:57Z","timestamp":1793506257751,"version":"4.5.0"},"reference-count":38,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>In medicine, inflammation is a fuzzy, overused word first coined by the Romans, the intended meaning and precise definition of which varies according to the person and the clinical context. It tends to carry a negative connotation as a response gone awry, like a raging, out-of-control wildfire that requires immediate control and containment lest it destroy all in its path; however, frequently overlooked or lost in the shuffle is the primordial importance of inflammation to health and survival. The precise definition of inflammation matters for several reasons, not least because of the over-liberal use of anti-inflammatory drugs to inhibit inflammation, which may, contrary to prevailing dogma that all inflammation is harmful, act counterproductively to prevent restitutio ad integrum. Using fire as a central analogy, this overview attempts to define inflammation, the better to determine how to manage it, i.e., whether to fan its flames, let it burn out, or suppress it entirely.<\/jats:p>","DOI":"10.3390\/ijms232314905","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T01:42:02Z","timestamp":1669686122000},"page":"14905","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":94,"title":["What Exactly Is Inflammation (and What Is It Not?)"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3940-6329","authenticated-orcid":false,"given":"Bryan","family":"Oronsky","sequence":"first","affiliation":[{"name":"EpicentRx Torrey Pines California, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Caroen","sequence":"additional","affiliation":[{"name":"EpicentRx Torrey Pines California, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Reid","sequence":"additional","affiliation":[{"name":"EpicentRx Torrey Pines California, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fimmu.2018.00038","article-title":"Bioactive Lipids and Chronic Inflammation: Managing the Fire Within","volume":"9","author":"Leuti","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3389\/fmed.2018.00316","article-title":"Inflammation-Nature\u2019s Way to Efficiently Respond to All Types of Challenges: Implications for Understanding and Managing \u201cthe Epidemic\u201d of Chronic Diseases","volume":"5","author":"Bennett","year":"2018","journal-title":"Front. Med."},{"key":"ref_3","first-page":"e20200147","article-title":"Once upon a time, inflammation","volume":"27","author":"Cavaillon","year":"2021","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1200\/JOP.2016.020347","article-title":"Functio Laesa: Cancer Inflammation and Therapeutic Resistance","volume":"13","author":"Liu","year":"2017","journal-title":"J. Oncol. Pract."},{"key":"ref_5","unstructured":"Hannoodee, S., and Nasuruddin, D.N. (2022). Acute Inflammatory Response. StatPearls, StatPearls Publishing."},{"key":"ref_6","unstructured":"Pahwa, R., Goyal, A., and Jialal, I. (2022). Chronic Inflammation. StatPearls, StatPearls Publishing."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ajpath.2020.08.009","article-title":"Immunopathology of Hyperinflammation in COVID-19","volume":"191","author":"Gustine","year":"2020","journal-title":"Am. J. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs","volume":"9","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fimmu.2016.00160","article-title":"Resolution of Inflammation: What Controls Its Onset?","volume":"7","author":"Sugimoto","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"699563","DOI":"10.3389\/fimmu.2021.699563","article-title":"DAMPs and Innate Immune Training","volume":"12","author":"Jentho","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_11","first-page":"e9","article-title":"The Role of Damage-Associated Molecular Patterns in Human Diseases: Part I-Promoting inflammation and immunity","volume":"15","author":"Land","year":"2015","journal-title":"Sultan. Qaboos. Univ. Med. J. [SQUMJ]"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1128\/microbiolspec.MCHD-0001-2014","article-title":"Macrophage Proresolving Mediators\u2014the When and Where","volume":"4","author":"Dalli","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2217\/imt-2016-0002","article-title":"Immune checkpoint inhibitor combinations in solid tumors: Opportunities and challenges","volume":"8","author":"Kyi","year":"2016","journal-title":"Immunotherapy"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.4049\/jimmunol.1201806","article-title":"Sepsis chronically in MARS: Systemic cytokine responses are always mixed regardless of the outcome, magnitude, or phase of sepsis","volume":"189","author":"Osuchowski","year":"2012","journal-title":"J. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"},{"key":"ref_16","first-page":"E633","article-title":"Fever: Suppress or let it ride?","volume":"7","author":"Ray","year":"2015","journal-title":"J. Thorac. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"H\u00e9bert, J.R., and Hofseth, L.J. (2022). Chapter 17\u2014Following the long arc of history: Where do we go from here?. Diet, Inflammation, and Health, Academic Press.","DOI":"10.1016\/B978-0-12-822130-3.00007-7"},{"key":"ref_18","unstructured":"Patel, P.H., and Hashmi, M.F. (2022, November 01). Macrolides, StatPearls, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK551495\/."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Heard, K.J., Ries, N.L., Dart, R.C., Bogdan, G.M., Zallen, R.D., and Daly, F. (2008). Overuse of non-prescription analgesics by dental clinic patients. BMC Oral Health, 8.","DOI":"10.1186\/1472-6831-8-33"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaci.2013.12.1088","article-title":"Mechanisms of allergen-specific immunotherapy: Multiple suppressor factors at work in immune tolerance to allergens","volume":"133","author":"Akdis","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e12476","DOI":"10.15252\/emmm.202012476","article-title":"Hydroxychloroquine in rheumatic autoimmune disorders and beyond","volume":"12","author":"Nirk","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000441054","article-title":"Dapsone as Second-Line Treatment for Cutaneous Lupus Erythematosus? A Retrospective Analysis of 34 Patients and a Review of the Literature","volume":"232","author":"Klebes","year":"2016","journal-title":"Dermatology"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Tran, S., Ksajikian, A., Overbey, J., Li, P., and Li, Y. (2022). Pathophysiology of Pulmonary Fibrosis in the Context of COVID-19 and Implications for Treatment: A Narrative Review. Cells, 11.","DOI":"10.2196\/preprints.37834"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"173854","DOI":"10.1016\/j.ejphar.2021.173854","article-title":"Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic","volume":"894","author":"Noreen","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref_25","first-page":"e432","article-title":"Going Further: Comprehensive Disease Control of Rheumatoid Arthritis, Targeting Cytokines and Chemokines","volume":"27","year":"2021","journal-title":"J. Clin. Rheumatol. Pract. Rep. Rheum. Musculoskelet. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Longo, M., Zatterale, F., Naderi, J., Rubio-Arrellano, E.D., and Duran-Barragan, S. (2019). Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20092358"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/psyp.12549","article-title":"Social support moderates the relationship between sleep and inflammation in a population at high risk for developing cardiovascular disease","volume":"52","author":"Tomfohr","year":"2015","journal-title":"Psychophysiology"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Iddir, M., Brito, A., Dingeo, G., Fernandez Del Campo, S.S., Samouda, H., La Frano, M.R., and Bohn, T. (2020). Strengthening the Immune System and Reducing Inflammation and Oxidative Stress through Diet and Nutrition: Considerations during the COVID-19 Crisis. Nutrients, 12.","DOI":"10.3390\/nu12061562"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.it.2020.05.007","article-title":"Where There\u2019s Smoke, There\u2019s Fire: Inflammation Drives MDS","volume":"41","author":"Datar","year":"2020","journal-title":"Trends Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"16493","DOI":"10.1073\/pnas.1113711108","article-title":"Cooling the fires of inflammation","volume":"108","author":"Kim","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4189516","DOI":"10.34133\/2021\/4189516","article-title":"The Dynamic Inflammatory Tissue Microenvironment: Signality and Disease Therapy by Biomaterials","volume":"2021","author":"Mata","year":"2021","journal-title":"Research"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev.pathmechdis.3.121806.151456","article-title":"The inflammatory response to cell death","volume":"3","author":"Rock","year":"2008","journal-title":"Annu. Rev. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.4049\/jimmunol.1301539","article-title":"Processes of Sterile Inflammation","volume":"191","author":"Shen","year":"2013","journal-title":"J. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/ni.2404","article-title":"Maintaining system homeostasis: The third law of Newtonian immunology","volume":"13","author":"Germain","year":"2012","journal-title":"Nat. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pharmthera.2015.11.011","article-title":"Small molecules with anti-inflammatory properties in clinical development","volume":"157","author":"Hanke","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"ref_36","first-page":"597","article-title":"An ounce of prevention: A pound of cure for an ailing health care system","volume":"53","author":"Genuis","year":"2007","journal-title":"Can. Fam. Physician"},{"key":"ref_37","first-page":"44","article-title":"New Insights Regarding Rationale, Therapeutic Target and Dose of Hemofiltration and Hybrid Therapies in Septic Acute Kidney Injury","volume":"33","author":"Jacobs","year":"2011","journal-title":"Blood Purif."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Slaats, J., Ten Oever, J., van de Veerdonk, F.L., and Netea, M.G. (2016). IL-1\u03b2\/IL-6\/CRP and IL-18\/ferritin: Distinct Inflammatory Programs in Infections. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005973"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/23\/14905\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:28:44Z","timestamp":1760146124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/23\/14905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,28]]},"references-count":38,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["ijms232314905"],"URL":"https:\/\/doi.org\/10.3390\/ijms232314905","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,28]]}}}